IM-12 100 mg | 99.42%
TargetMol
IM-12, an effective GSK-3β inhibitor(IC50=53 nM), regulates Wnt signalling.
More Information Supplier PageIM-12
Search Results
IM-12 25 mg | 99.42%
TargetMol
IM-12, an effective GSK-3β inhibitor(IC50=53 nM), regulates Wnt signalling.
More Information Supplier PageIM-12
IM-12 5 mg | 99.42%
TargetMol
IM-12, an effective GSK-3β inhibitor(IC50=53 nM), regulates Wnt signalling.
More Information Supplier PageIM-12
ICG001 50 mg | 98.63%
TargetMol
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CREB)-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300.
More Information Supplier PageICG001
ICG001 10 mg | 98.63%
TargetMol
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CREB)-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300.
More Information Supplier PageICG001
ICG001 2 mg | 98.63%
TargetMol
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CREB)-binding protein (CBP) with IC50 of 3 μM, but is not the related transcriptional coactivator p300.
More Information Supplier PageICG001
8-Azaguanine 200 mg | Purity Not Available
TargetMol
8-Azaguanine is a purine analogue with potential antineoplastic activity.
More Information Supplier Page8-Azaguanine
ITD-1 25 mg | 99.89%
TargetMol
ITD-1
ITD-1 100 mg | 99.89%
TargetMol
ITD-1
SGX-523 25 mg | 99.60%
TargetMol
SGX-523 is a selective Met inhibitor (IC50: 4 nM), no inhibitory to Abl, BRAFV599E, p38α, and c-Raf.
More Information Supplier PageSGX-523
